Vince Siu

Dr. Vince Siu

Digital Health, IBM Research - Thomas J. Watson Research Center, Yorktown Heights, USA
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2011 in Nano Letters
Verified
Journal Article
Closed access
JFJing Feng
Jing Feng
Vince SiuVince Siu
Vince Siu
ARAlec Roelke
Alec Roelke
VMVihang Mehta
Vihang Mehta
SRSteve Y. Rhieu
Steve Y. Rhieu
DPDomenico Pacifici
Domenico Pacifici

18 December 2017 in Applied Physics Letters
Verified
Journal Article
Closed access
Huan HuHuan Hu
Huan Hu
Vince SiuVince Siu
Vince Siu
SGStacey M. Gifford
Stacey M. Gifford
SKSungcheol Kim
Sungcheol Kim
MLMinhua Lu
Minhua Lu
GSGustavo A. Stolovitzky
Gustavo A. Stolovitzky
The recently discovered bactericidal properties of nanostructures on wings of insects such as cicadas and dragonflies have inspired the development of similar nanostructured surfaces for antibacterial applications. Since most antibacterial applications require nanostructures covering a considerable amount of area, a practical fabrication method needs to be cost-effective and scalable. However, most reported nanofabrication methods require either expensive equipment or a high temperature process, limiting cost efficiency and scalability. Here, we report a simple, fast, low-cost, and scalable antibacterial surface nanofabrication methodology. Our method is based on metal-assisted chemical etching that only requires etching a single crystal silicon substrate in a mixture of silver nitrate and hydrofluoric acid for several minutes. We experimentally studied the effects of etching time on the morphology of the silicon nanospikes and the bactericidal properties of the resulting surface. We discovered that 6 minutes of etching results in a surface containing silicon nanospikes with optimal geometry. The bactericidal properties of the silicon nanospikes were supported by bacterial plating results, fluorescence images, and scanning electron microscopy images.

1 October 2009 in Electrochemistry Communications
Verified
Journal Article
Closed access
SRSteve Y. Rhieu
Steve Y. Rhieu
DLDaniel R. Ludwig
Daniel R. Ludwig
Vince SiuVince Siu
Vince Siu
GPG. Tayhas R. Palmore
G. Tayhas R. Palmore

22 March 2022 in ACS Omega
Verified
Journal Article
Open access
Vince SiuVince Siu
Vince Siu
MLMinhua Lu
Minhua Lu
KHKuan Yu Hsieh
Kuan Yu Hsieh
KRKierstyn Raines
Kierstyn Raines
YAYoussef A. Asaad
Youssef A. Asaad
RBRussell Budd
Russell Budd
This paper reports on a low-cost, quantitative, point-of-care solution for the early detection of nitrite, a common biomarker for urinary tract infections (UTIs). In a healthy individual, nitrite is not found in the urine. However, a subject with a suspected UTI will produce nitrite in their urine since the bacteria present will convert nitrate into nitrite. Traditionally, nitrite is monitored by urinary dipsticks that are either read by eye or using a reflectance spectrophotometer. Both methods provide a semiquantitative positive or negative result at best. In this paper, we described a novel, affordable, portable transmission-based colorimeter for the quantitative measurement of nitrite. A unique permutation of the Griess reaction was optimized for the clinical detection of nitrite in urine and is reported. By using nitrite spiked in a salt buffer, artificial, and human urine samples, the performance of the colorimeter was evaluated against dipsticks read using two commercial dipstick analyzers, Urisys 1100 (Roche Diagnostics) and Clinitek Status+ (Siemens Medical Solutions). The colorimeter was able to detect the clinically relevant range of nitrite from 0.78 to 200 μM in a salt buffer. The detection limit in artificial urine was determined as 1.6 μM, which is ∼16× more sensitive than commercial dipstick reflectance analyzers, enabling the possibility for earlier detection of urinary infections. The colorimeter is assembled using off-the-shelf components (<$80) and controlled by a smartphone application via low-energy bluetooth. It has a built-in color correction algorithm and is designed to enable for a turbidity correction in samples containing bacteria or other cellular debris as well. The mobile application can display the nitrite concentration for a single sample or display the results over a period of time. Tracking urinalysis results longitudinally can help identify trends such as increases in nitrite concentrations over an individual's baseline and identify possible infections earlier. While the detection of nitrite was showcased here, this portable analyzer can be expanded to other colorimetric-based chemistries to detect a panel of biomarkers, which can improve the overall sensitivity and specificity of the desired assay.

6 May 2014 in Nanophotonics
Verified
Journal Article
Closed access
PDF file
Vince SiuVince Siu
Vince Siu
JFJing Feng
Jing Feng
PFPatrick W. Flanigan
Patrick W. Flanigan
GPG. Tayhas R. Palmore
G. Tayhas R. Palmore
DPDomenico Pacifici
Domenico Pacifici

1 July 2022
Verified
Conference Paper
Closed access
BWBo Wen
Bo Wen
Vince SiuVince Siu
Vince Siu
IBItalo Buleje
Italo Buleje
KHKuan Yu Hsieh
Kuan Yu Hsieh
TITakashi Itoh
Takashi Itoh
JRJeffrey L. Rogers
Jeffrey L. Rogers
This paper highlights the design philosophy and architecture of the Health Guardian, a platform developed by the IBM Digital Health team to accelerate discoveries of new digital biomarkers and development of digital health technologies. The Health Guardian allows for rapid translation of artificial intelligence (AI) research into cloud-based microservices that can be tested with data from clinical cohorts to understand disease and enable early prevention. The platform can be connected to mobile applications, wearables, or Internet of things (IoT) devices to collect health-related data into a secure database. When the analytics are created, the researchers can containerize and deploy their code on the cloud using pre-defined templates, and validate the models using the data collected from one or more sensing devices. The Health Guardian platform currently supports time-series, text, audio, and video inputs with 70+ analytic capabilities and is used for non-commercial scientific research. We provide an example of the Alzheimer's disease (AD) assessment microservice which uses AI methods to extract linguistic features from audio recordings to evaluate an individual's mini-mental state, the likelihood of having AD, and to predict the onset of AD before turning the age of 85. Today, IBM research teams across the globe use the Health Guardian internally as a test bed for early-stage research ideas, and externally with collaborators to support and enhance AI model development and clinical study efforts.